AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio

AntlerA Norrin/Wnt-agonist antibody, through a strategic partnership with EyeBio, has entered clinical trials for treatment of retinopathies.

Genomic Vision 1881778573

Genomic Vision secures distribution agreement with CliniSciences

Genomic Vision, a Euronext-listed biotechnology company that develops products and services for the characterization of DNA sequences, has secured an exclusive European distribution agreement with CliniSciences.

GBA USA

GBA Group enters US market to support growing demand from international clients

GBA Group, a leading European life science service provider, has entered the U.S. market with a site in Westborough, Massachusetts to support clinical trials. Located in the greater Boston area, a pharmaceutical and biotech hub, the laboratory and logistics site will be fully operational in October this year and will offer a broad range of […]

Samantha Macro

CN Bio appoints Dr Samantha Macro as CFO

Appointment part of company’s ambitious global growth strategy CN Bio, one of the world’s leading Organ-on-a-Chip companies has appointed Dr Samantha Macro as Chief Financial Officer. Dr Macro joins CEO, Dr Paul Brooks, on the executive board to guide key commercial and strategic initiatives, increase revenue and shape the company’s growth trajectory.

avacta acquires coris

Avacta Group acquires Coris Bioconcept

Avacta Group has acquired Coris Bioconcept for £7.4 million and an extra £3 million payout based on future business performance.

Scherm­afbeelding 2023 07 06 om 20.52.31 1

Werfen – Acute Care Diagnostics

Integrative solutions at the speed of life

Scherm­afbeelding 2023 07 06 om 20.51.02

Werfen – Acute Care Diagnostics

The Intelligent Analyzer

Scherm­afbeelding 2023 07 06 om 20.51.46

Euroimmun – EASY. EFFICIENT. EXCEPTIONAL. Fully automated IIFT from primary sample to fi nal result

EASY. EFFICIENT. EXCEPTIONAL. Fully automated IIFT from primary sample to fi nal result

Scherm­afbeelding 2023 07 07 om 11.59.15

Plasma Volume Is Associated with Patient Mortality, ICU Days, and Ventilator Days

Patients with acute respiratory distress syndrome (ARDS) are particularly vulnerable to adverse effects of fluid overload. Plasma volume status (PVS), defined as the percentage deviation from ideal plasma volume, has emerged as a rapid, noninvasive method to assess volume status and prognosis:1

Scherm­afbeelding 2023 07 06 om 19.46.59

Quantimetrix Urinalysis & Microscopics Controls

Simple. Efficient. Versatile.